Bradsaúde (SAUD3) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
2 Jul, 2026Executive summary
Surpassed 8.8 million beneficiaries, with net addition of 55,000 Bradesco Dental SME lives in 3Q24 and 292,000 net new members in the last twelve months.
Net income per share rose 16% year-over-year in Q3 2024; net income reached R$142 million in 3Q24, up 15% YoY, and R$546 million in the last twelve months, with a 100% payout via dividends and interest on capital.
Adjusted EBITDA for 3Q24 was R$177 million, up 13% year-over-year, with margin expansion to 30.9%.
Bradesco Dental brand now accounts for 80% of SME customer base.
Recognized as a Great Place to Work and Top of Mind Award winner for the 11th consecutive year.
Financial highlights
Net operating revenue was R$571 million in 3Q24 (+4.6% YoY), and R$2.23 billion in the last twelve months (+5.4% YoY).
Adjusted EBITDA margin reached 30.9% in 3Q24 and 30.7% LTM, with net margin at 24.8%.
Net financial income in 3Q24 was R$27.4 million, up 41.7% year-over-year.
Dental loss ratio improved to 38% in 3Q24, down 5 p.p. YoY, supporting margin expansion.
Cash flow from operations in 9M24 was R$508.3 million, with net cash of R$1.14 billion and zero debt.
Outlook and guidance
Strategy focuses on accelerating growth in the non-corporate segment, especially SME and Individual, leveraging bancassurance and digital distribution channels.
Digital initiatives maturing in 2024 are expected to reduce future CAPEX and drive SG&A efficiency in 2025 and 2026.
Cost per life expected to gradually increase, but loss ratio to remain controlled and below 40%.
Latest events from Bradsaúde
- Revenue up 5.9%, net income R$539M, 97% payout, R$913M net cash, no debt.SAUD3
Q4 20242 Jul 2026 - 2Q24 delivered strong growth, record margins, and a 100% net income payout to shareholders.SAUD3
Q2 20242 Jul 2026 - R$13.4B revenue and R$1.3B net income in 1Q26, with robust growth and major restructuring.SAUD3
Q1 202621 May 2026 - Membership and revenue growth fueled margin expansion and strong cash generation in 2025.SAUD3
Q4 20258 Apr 2026 - High-margin, tech-focused dental insurer grows SME segment, sustains top dividends, and zero debt.SAUD3
Status update28 Jan 2026 - Record SME and Individual plan growth, margin expansion, and strong cash generation.SAUD3
Q2 202523 Nov 2025 - EBITDA margin rose to 38.3% in Q1 2025, led by SME and individual segment growth.SAUD3
Q1 202519 Nov 2025 - Record SME and Individual plan growth drove revenue, margin, and shareholder return gains.SAUD3
Q3 202513 Nov 2025